Trial intelligence / Profile preview

Multimodal Therapies for Pediatric Acute Diarrhea

NCT06588036Phase 1Not yet recruiting

Sponsor
Combined Military Hospital Multan
Start
Sep 2024
Primary completion
Dec 2024
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of diosmectite in acute diarrhea (4 arms), sponsored by Combined Military Hospital Multan. Primary endpoint: Mean time from the initiation of treatment to the resolution of diarrhea symptoms at 3 months. Planned start Sep 2024; status: not yet recruiting.

02

Drugs

diosmectite
03

Conditions

acute diarrhea

Beyond the preview

Go deeper on NCT06588036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06588036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call